Speaker illustration

Professor Simon Lebek

University Hospital Regensburg, Regensburg (Germany)

Member of:

European Society of Cardiology

Prof. Dr. Simon Lebek, FESC studied Medicine in Regensburg (Germany), where he received his doctoral degree in the laboratory of Prof. Dr. Lars Maier by studying myocardial function and pathology in various cardiac disorders. After completing his habilitation in Experimental Internal Medicine, Dr. Lebek joined the laboratory of Prof. Dr. Eric Olson at the UTSW Medical Center in Dallas (USA), funded by the Walter Benjamin-fellowship of the German Research Foundation (DFG). There, he deployed CRISPR-Cas9 gene editing to disrupt pathogenic signaling as a therapeutic strategy for common cardiovascular diseases. In 2023, Simon Lebek was admitted to the DFG Heisenberg Program, which enabled him to launch an independent laboratory in Regensburg. Since April 2024, he is a Professor of Internal Medicine, Experimental Cardiology, and Gene Editing at the University Hospital Regensburg.

Ferroptosis and iron metabolism

Event: ESC Congress 2024

Topic: Basic Science

Session type: Moderated ePosters

Thumbnail

Novel targets against myocardial damage

Event: ESC Congress 2024

Topic: Cardiac Diseases

Session type: Abstract Sessions

Thumbnail